AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2020
May 5, 2020
35221_dirs_2020-05-04_49c9cf05-fc7c-490e-9213-40d5ae2d1992.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2020-04-30
Reporting Person: Glennon Michael J (Director, Vice Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | Employee Stock Option (Right to Buy) | $2.19 | A | 100000 | Acquired | 2030-04-30 | Common Stock (100000) | Direct |
Footnotes
F1: The option vests in 12 equal quarterly installments commencing on June 30, 2020.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23